Page 290 - DOENÇA MENINGOCÓCICA - VOLUME 2 - DIGITAL
P. 290

172) CARVALHO, A. A.; GIAMPAGLIA, C. M. S.; KIMURA, H.; PEREIRA, O. A. C.; FARHAT,;
                C. K.; NEVES, J. C.; PRANDIN,: R.; CARVALHO, E. S. & ZARVOS, A. M.; Maternal and
                infant antibody response to meningococcal vaccination in pregnancy. LANCET., London,
                2: 809-811, 1977.

                173) CHESTER, T. J.; JACOBSON, J. A.; CAVINESS, E. L.; & WOLF, F. S.; House-to-house,
                community-wide chemoprophylaxis for meningococcal disease: an aggressive approach to
                disease prevention. Am. J. Public. Health, New York., 67: 1058-1062, 1977.

                174) COSTA, E. A.; OSANAI, C. H.; TAKEDA, A. K.; CHIMELLI, M. & MELLO, JR, C. S.
                Estudo da resposta imunitária a vacinação anti-meningocócica com polissacarídeos de
                diversas procedências. Rev. Soc., Bras. Med., Trop., Rio de Janeiro, 11: 67-80, 1977.

                175) DUARTE, A. C. Sistema urbano. In Instituto Brasileiro de Geografia e Estatística.
                Geografia do Brasil, Região Sul. V. 5. p. 453-526.

                176) ETTORI, D.; SALIOU, P.; RENAUDET, J. & STOECKEL, Ph. Le vaccin
                antimeningococcique polysaccharidique du type A: premiers essais controles en Afrique
                de ouest. Med. Trop. Marseille, 37: 225-230, 1977.

                177) FOURRIER, A.; ANQUEZ, E.; MOUTON, Y.; CAILLAUX, M.; SOCOLOVSKY, C.;
                BEAUCAIRE, G. & DRACON, M. Enquête epidemiologique sur la méningite b em milieu
                ouvert et prophilaxie de La meningite cérébro-spinale. Lille Med., Lille, 22: 296-302, 1977.

                178) FRASCH, C. E. Role of protein serotype antigens in protection against disease due to
                Neisseria menincitidis. J. Infect. Dis., Chicago. 136 (Supplem.): S84-S90,1977.
                179) FRASCH., C. E. & FRIEDMAN, G. L. Identification d’um serotype meningococique
                associé a la maladie et. commun aux menigocoques des groupes B, C, Y et 135 W. Med.
                Trop., Marseille, 37: 155-159, 1977.

                180) GLODE, M. P.; ROBBINS:, J. B.; LIU, T-Y; GOTSCHLICH , E. C.; ORSKOV, I &
                ORSKOV, F. Cross-antigenicity and immunogenicity between capsular polysaccharides of
                group C Neisseria meningitidis and of Escherichia coli K92. J. Infect. Dis., Chicago, 135:
                94-102, 1977.

                181) GOLD, R.; LEPOW, M. L.; GOLDSCHNEIDER; I. & GOTSCHLICH; E. L. Immune
                response of human infants to polysaccharide vaccines of groups A e C Neisseria
                meningitidis. J. Infect. Dis., Chicago. 136 (Suppl.): S31-S37, 1977.

                182) GRIFISS, J. M.; BROUND, D. D.; SILVER, C. A. & ARTENSTEIN, M. S.
                Immunoepidemiology of meningococcal disease in military recruits. I. A model for
                serogroup independency of epidemic potential as determined by serotyping. J. Infect. Dis.,
                Chicago, 136: 176-186, 1977.

                183) GRIFISS, J. M. & BERTRAM, M. A. Immunoepidemiology of meningococcal disease
                in military recruits. II. Blocking of serum bactericidae activity by circulating Ig A early in
                the course of invasive disease. J.  Infect. Dis., Chicago, 136: 733-739, 1977.




                                                        288
   285   286   287   288   289   290   291   292   293   294   295